RxSight Inc. (RXST)
RxSight Statistics
Share Statistics
RxSight has 40.64M shares outstanding. The number of shares has increased by 3.87% in one year.
| 40.64M |
| 3.87% |
| 0.46% |
| 88.77% |
| n/a |
| 26 |
| n/a |
Short Selling Information
The latest short interest is 4.92M, so 12.11% of the outstanding shares have been sold short.
| 4.92M |
| 12.11% |
| 12.72% |
| 3.85 |
Valuation Ratios
The PE ratio is -48.67 and the forward PE ratio is -28.76. RxSight's PEG ratio is 0.98.
| -48.67 |
| -28.76 |
| 9.55 |
| 2.6 |
| 4.75 |
| -59.69 |
| 0.98 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for RxSight.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 11.36, with a Debt / Equity ratio of 0.04.
| 11.36 |
| 10.5 |
| 0.04 |
| -0.52 |
| -0.55 |
| -1755.14 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $280,977.91 |
| $-55,130.52 |
| 498 |
| 0.44 |
| 1.86 |
Taxes
| 50K |
| -0.18% |
Stock Price Statistics
The stock price has increased by -74.62% in the last 52 weeks. The beta is 1.29, so RxSight's price volatility has been higher than the market average.
| 1.29 |
| -74.62% |
| 16.22 |
| 34.9 |
| 44.77 |
| 1,039,177 |
Income Statement
In the last 12 months, RxSight had revenue of 139.93M and earned -27.45M in profits. Earnings per share was -0.71.
| 139.93M |
| 98.94M |
| -36.86M |
| -27.45M |
| -23.76M |
| -27.38M |
| -0.71 |
Balance Sheet
The company has 16.71M in cash and 12.3M in debt, giving a net cash position of 4.41M.
| 16.71M |
| 12.3M |
| 4.41M |
| -622.1M |
| 313.04M |
| 265.67M |
Cash Flow
In the last 12 months, operating cash flow was -16.95M and capital expenditures -5.44M, giving a free cash flow of -22.39M.
| -16.95M |
| -5.44M |
| -22.39M |
| -0.58 |
Margins
Gross margin is 70.71%, with operating and profit margins of -26.34% and -19.62%.
| 70.71% |
| -26.34% |
| -19.59% |
| -19.62% |
| -16.98% |
| -26.34% |
| -16% |
Dividends & Yields
RXST does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for RXST is $32, which is 114.8% higher than the current price. The consensus rating is "Buy".
| $32 |
| 114.8% |
| Buy |
| 10 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 10.13 |
| 3 |